Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update October 2022

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Guideline News September 2022

The GGC Clostridioides difficile guideline has been updated to reflect changes to the NICE guideline [NG199] Clostridioides difficile infection: antimicrobial prescribing.

HEPMA Update 2– October 2022

Key Medicine Shortages – October 2022

MHRA Drug Safety Update September 2022

• Sodium hyaluronate eye drops are on the NHSGGC Adult Medicines Formulary restricted to use in severe dry eye only

• Blink Intensive Tears® (sodium hyaluronate 0.2%) eye drops (containing a preservative) are considered the first line sodium hyaluronate preparation.

• Eyeaze® 0.4% (sodium hyaluronate 0.4%) preservative free eye drops have been added to the NHSGGC Adult Medicines Formulary following a Formulary appeal.

HEPMA Update – September 2022